FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems
Posted by
The Nurse Practitioners of New York
on
Manhattan, NY
Please CLICK HERE to view the article
Source: FDA